Blog Layout

New palliative care physician joining the Ballarat Cancer Care team
December 3, 2024

We are pleased to announce palliative care physician Dr Russell Pearce will be joining our team in February 2025.


Russell is a Palliative Care Physician who grew up in Alexandra, a rural town in Victoria, before moving to Ballarat in 2013 to undertake his medical training. He completed General Practice training through the Royal Australian College of General Practitioners in Ballarat and subsequently specialised in Palliative Medicine through the Royal Australasian College of Physicians. His specialist training included experiences at Ballarat, Bendigo, Geelong, and the Monash and Austin Hospitals.

 

Russell provides care for individuals with life-limiting illnesses, including both cancer and non-cancer conditions. He focuses on managing complex physical and emotional symptoms, assisting with advance care planning, and ensuring coordinated, multidisciplinary care tailored to each patient’s needs.


With extensive experience in both urban and regional healthcare settings, Russell is dedicated to ensuring accessible, high-quality palliative care for patients in Ballarat and surrounding areas. He has a particular interest in facilitating care for people affected by disabilities, working to address their unique needs and challenges within the healthcare system.


Outside of work, Russell enjoys running, reading science fiction and fantasy novels, and spending time with his family.


Dr Russell Pearce - Ballarat Cancer Care
Haematologist Dr Marsali Maclean joins Ballarat Cancer Care
February 16, 2025
Haematologist Dr Marsali Maclean joins Ballarat Cancer Care
New haematologist  joining the Ballarat Cancer Care team
August 27, 2024
We are excited to announce Dr Tishya Indran will be joining our team as of 18th September 2024. 
4th Dose COVID-19 Vaccine for Immunocompromised Patients
March 1, 2022
The Australian Technical Advisory Group on Immunisation (ATAGI) has approved a fourth dose of a COVID-19 vaccine for people with weakened immune systems. People aged 18 years or older with weakened immune system who received a 3-dose primary course of the COVID-19 vaccine are now recommended to receive the fourth dose ≥ 3 months after their third dose. This is expected to improve protection against symptomatic infection, serious illness, or death from COVID-19 infection.
COVID-19 Vaccine Booster Shots In Our Patients With Cancer
November 8, 2021
The Government and the Medical advisory group (ATAGI) have release new recommendations last week for individuals who are severely immunocompromised in regards to the COVID-19 vaccine. These recommendations will affect some (but not all) of our patients. As always, we are happy to discuss any of the recommendations further with all of our patients.
COVID-19 Vaccination FAQs July 2021
July 20, 2021
In the last few months, I have been inundated with many questions regarding COVID-19 vaccination and blood clots from patients and other health practitioners. In this article, I have compiled these frequently asked questions.
New PBS listings!
July 2, 2021
Despite a global pandemic, new data relating to oncology treatments continues to be published, and it seems that this is increasingly translating into improved drug access here in Australia.
Astra Zeneca (AZ) vaccine safety information
March 26, 2021
In light of recent reports of clotting events following Astra Zeneca (AZ) vaccine in Europe - we have been frequently asked questions regarding the safety of AZ vaccine in patients with previous clot events and/or blood problems
February 25, 2021
Two vaccines against the coronavirus have now been approved for use in Australia, role-out of the vaccine begins this week in high-risk populations.
January 18, 2021
Dr Swe Myo Htet Consultant Haematologist MBBS, FRACP, FRCPA, MRCP
Blood clot disorder and long distance car-travel
December 2, 2020
Blood specialist, Dr. Pohan Lukito, answers frequently asked question regarding blood clot disorder and long distance car-travel
More Posts
Share by: